Re: Level 2
|
2
|
Resverlogix Corp.
|
Nov 13, 2015 11:50AM
|
Further Funding
|
2
|
Resverlogix Corp.
|
Apr 28, 2017 11:04AM
|
Re: go hard or go home
|
2
|
Resverlogix Corp.
|
Jun 08, 2017 12:20AM
|
Re: Best answer Jay!
|
2
|
Resverlogix Corp.
|
Nov 12, 2015 03:18PM
|
Re: Wonderful
|
2
|
Resverlogix Corp.
|
Aug 28, 2017 10:54AM
|
Re: The thread has been killed
|
2
|
Resverlogix Corp.
|
Jun 12, 2019 05:13PM
|
Re: The meaning of 88
|
1
|
Resverlogix Corp.
|
Aug 17, 2018 10:10AM
|
Re: VOLUME
|
1
|
Resverlogix Corp.
|
Jun 28, 2021 01:18PM
|
Re: pfizer
|
1
|
Resverlogix Corp.
|
Dec 15, 2020 08:36PM
|
Re: Resverlogix Announces Apabetalone Prior to SARS-CoV-2 (COVID-19) Exposure Reduces Viral Infection – Confirms Plans for COVID-19 Clinical Trial
|
1
|
Resverlogix Corp.
|
Dec 22, 2020 10:28AM
|
Re: Resverlogix Announces Apabetalone Prior to SARS-CoV-2 (COVID-19) Exposure Reduces Viral Infection – Confirms Plans for COVID-19 Clinical Trial
|
1
|
Resverlogix Corp.
|
Dec 22, 2020 10:35AM
|
Re: RESVERLOGIX ANNOUNCES PUBLICATION OF KEY APABETALONE STUDY BETONMACE IN THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
|
1
|
Resverlogix Corp.
|
Mar 30, 2020 07:03PM
|
One reason for being pulled....
|
1
|
Resverlogix Corp.
|
May 14, 2021 11:49AM
|
Re: Stockhouse posters.....
|
|
Resverlogix Corp.
|
Sep 07, 2018 10:11AM
|